Holding(s) in Company

Dechra Pharmaceuticals PLC

27 December 2023

 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB0009633180

Issuer Name

DECHRA PHARMACEUTICALS PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

JPMorgan Chase & Co.

City of registered office (if applicable)

Country of registered office (if applicable)

US

4. Details of the shareholder

Name	City of registered office	Country of registered office
J.P. Morgan Securities plc

5. Date on which the threshold was crossed or reached

22-Dec-2023

6. Date on which Issuer notified

27-Dec-2023

7. Total positions of person(s) subject to the notification obligation

	% of voting rights attached to shares (total of 8.A)	% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)	Total of both in % (8.A + 8.B)	Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached	4.232874	2.765849	6.998723	7971082
Position of previous notification (if applicable)	4.232906	2.774841	7.007747

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)	Number of direct voting rights (DTR5.1)	Number of indirect voting rights (DTR5.2.1)	% of direct voting rights (DTR5.1)	% of indirect voting rights (DTR5.2.1)
GB0009633180		4820962		4.232874
Sub Total 8.A	4820962		4.232874%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument	Expiration date	Exercise/conversion period	Number of voting rights that may be acquired if the instrument is exercised/converted	% of voting rights
Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument	Expiration date	Exercise/conversion period	Physical or cash settlement	Number of voting rights	% of voting rights
Cash-settled Equity Swap	20/02/2024	20/02/2024	Cash	6220	0.005461
Cash-settled Equity Swap	04/03/2024	04/03/2024	Cash	5090	0.004469
Cash-settled Equity Swap	05/06/2024	05/06/2024	Cash	1420344	1.247082
Cash-settled Equity Swap	27/06/2024	27/06/2024	Cash	1415	0.001242
Cash-settled Equity Swap	12/07/2024	12/07/2024	Cash	1390089	1.220518
Cash-settled Equity Swap	31/07/2024	31/07/2024	Cash	39012	0.034253
Cash-settled Equity Swap	17/10/2024	17/10/2024	Cash	68288	0.059958
Cash-settled Equity Swap	04/11/2024	04/11/2024	Cash	17	0.000015
Cash-settled Equity Swap	20/11/2024	20/11/2024	Cash	2468	0.002167
Cash-settled Equity Swap	27/12/2024	27/12/2024	Cash	4058	0.003563
Cash-settled Equity Swap	22/01/2025	22/01/2025	Cash	202956	0.178198
Cash-settled Equity Swap	04/02/2025	04/02/2025	Cash	2838	0.002492
Cash-settled Equity Swap	16/01/2026	16/01/2026	Cash	420	0.000369
Cash-settled Equity Swap	18/06/2027	18/06/2027	Cash	6891	0.006050
Cash-settled Equity Swap	30/05/2028	30/05/2028	Cash	14	0.000012
Sub Total 8.B2				3150120	2.765849%

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person	Name of controlled undertaking	% of voting rights if it equals or is higher than the notifiable threshold	% of voting rights through financial instruments if it equals or is higher than the notifiable threshold	Total of both if it equals or is higher than the notifiable threshold
JPMorgan Chase & Co.	J.P. Morgan Securities plc	4.193702		6.959551%
JPMorgan Chase & Co.	J.P. Morgan Securities LLC
JPMorgan Chase & Co.	J.P. Morgan SE

10. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional Information

12. Date of Completion

27-Dec-2023

13. Place Of Completion

London, United Kingdom

 

END